11月28日，金陵药业股份有限公司（证券代码：000919，简称"金陵药业"）发布公告称，公司第九届董 事会第二十二次会议审议通过《关于清算注销湖州邦健天峰药业有限公司的议案》，同意对全资子公司 湖州邦健天峰药业有限公司（简称"邦健天峰"）实施清算注销。本次事项无需提交股东大会审议，不涉 及关联交易及重大资产重组。 登录新浪财经APP 搜索【信披】查看更多考评等级 金陵药业表示，本次清算注销主要因邦健天峰经营业务持续萎缩，为进一步优化公司资源配置、降低管 理成本、提高运营效率而作出的审慎决策。公告特别强调，本次注销不涉及人员安置及债务重组，公司 未为其提供担保、财务资助或委托理财，邦健天峰亦无占用公司资金的情况。 根据安排，清算注销完成后，邦健天峰将不再纳入公司合并财务报表范围。金陵药业指出，该事项不会 对公司本期及未来财务状况、经营成果产生重大影响，亦不会对整体业务发展形成实质性冲击，不存在 损害股东利益的情形。公司将根据清算进展履行后续信息披露义务。 备查文件显示，本次议案已获董事会审议通过，相关清算工作将依据法律法规要求推进。 拟注销子公司经营持续萎缩 2025年前三季度营收仅1400元 公告显示，邦健 ...

Group 1 - SMIC announced the termination of the sale of its stake in SMIC Ningbo due to failure to reach an agreement within the expected timeframe, retaining a 14.832% stake post-termination, with no significant impact on financial status [2] - Chaozhuo Aerospace's actual controller will change to Hubei State-owned Assets Supervision and Administration Commission, with stock resuming trading on December 1 [2] - ST Lifan faces potential forced delisting due to false disclosures in its 2021-2023 annual reports, with a total false revenue of 592 million yuan, representing 50.91% of the reported revenue for those years [3] Group 2 - Lijun Holdings' subsidiary signed a contract worth approximately 57.6 million USD for high-pressure roller mills, accounting for 52.53% of the audited consolidated revenue for 2024, expected to positively impact future performance [3] - Sanjiang Shopping's second-largest shareholder, Alibaba Zeta, reduced its stake by 5.4768 million shares, decreasing its holding from 30% to 29% [4] - Tianfeng Securities is under investigation by the CSRC for suspected information disclosure violations and illegal financing [5] Group 3 - China Jushi's major shareholder, Zhenstone Group, plans to increase its stake by no less than 550 million yuan and no more than 1.1 billion yuan [6] - Helun Zhe's major shareholder received a notice of investigation for suspected information disclosure violations, which does not affect the company's operations [7] - Yongtai Energy's actual controller also received a notice of investigation for similar violations, with no impact on the company's operations [8] Group 4 - Wuhantian Source's major shareholder, Konka Group, plans to transfer 9.83% of its shares to China Resources Asset Management [9] - Pinggao Electric won a bid for a State Grid project worth approximately 773 million yuan [9] - Zhejiang Longsheng is collaborating with a private equity fund to establish a venture capital partnership [9]

格隆汇11月28日丨金陵药业(000919.SZ)公布，控股子公司南京梅山医院有限责任公司（简称"南京梅山 医院"或"医院"）为更好地满足辐射区域内民众日益增长的健康需求，进一步提升医院医疗设施水平与 服务能力，拟投资89,329.63万元（最终以实际投资金额为准）实施医院改扩建项目。项目建设内容：主 要包括拆除工程、改造工程、新建工程、室外工程等土建安装工程，以及医疗专项和医疗设备购置。主 体工程为新建的门急诊医技病房综合楼，该工程共计地上12层，地下2层，主要功能为门诊、急诊、医 技及病房等。 ...

格隆汇11月28日丨金陵药业(000919.SZ)公布，第九届董事会第二十二次会议审议通过了《关于清算注 销湖州邦健天峰药业有限公司的议案》，同意公司全资子公司湖州邦健天峰药业有限公司（简称"邦健 天峰"）终止经营活动，并依据相关法律法规的要求对其进行清算注销。 ...

证券日报网讯 11月28日晚间，金陵药业发布公告称，2025年11月28日，公司第九届董事会第二十二次 会议审议通过了《关于清算注销湖州邦健天峰药业有限公司的议案》，同意公司全资子公司湖州邦健天 峰药业有限公司终止经营活动，并依据相关法律法规的要求对其进行清算注销。 （文章来源：证券日报） ...

（文章来源：证券日报） 证券日报网讯 11月28日晚间，金陵药业发布公告称，2025年11月28日，公司召开第九届董事会第二十 二次会议，审议通过了《关于南京梅山医院投资改扩建项目的议案》，同意公司控股子公司南京梅山医 院投资89，329.63万元（最终以实际投资金额为准）实施医院改扩建项目。 ...

格隆汇11月28日丨金陵药业(000919.SZ)公布，控股子公司南京梅山医院有限责任公司（简称"南京梅山 医院"或"医院"）为更好地满足辐射区域内民众日益增长的健康需求，进一步提升医院医疗设施水平与 服务能力，拟投资89,329.63万元（最终以实际投资金额为准）实施医院改扩建项目。项目建设内容：主 要包括拆除工程、改造工程、新建工程、室外工程等土建安装工程，以及医疗专项和医疗设备购置。主 体工程为新建的门急诊医技病房综合楼，该工程共计地上12层，地下2层，主要功能为门诊、急诊、医 技及病房等。 ...

Key Points - Guizhou Moutai elected Chen Hua as the chairman of the fourth board of directors and plans to repurchase shares between RMB 1.5 billion and RMB 3 billion [1] - Tianfeng Securities is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure and illegal financing [1] Share Buybacks - Demai Technology raised the upper limit for share repurchase to RMB 45 per share [5] - Jianbang Technology plans to repurchase shares worth between RMB 15 million and RMB 30 million [5] - Huayuan Holdings intends to repurchase shares worth between RMB 30 million and RMB 60 million [5] Major Investments - Jinling Pharmaceutical plans to invest RMB 893 million in hospital expansion projects [7] - Dongfang Mingzhu intends to invest approximately RMB 500 million to establish a partnership and acquire part of the equity of New H3C [7] - Chang'an Automobile aims to establish a robotics company to develop innovative products and solutions [7] Mergers and Acquisitions - Kaizhong Co. plans to acquire 60% of Anhui Tuosheng's equity, with stock resuming trading on December 1 [7] - Youa Co. has resumed the review process for issuing shares and cash to purchase assets [7] - Jiasheng Technology intends to acquire controlling interest in Shudun Information Technology Co., with stock continuing to be suspended [7] Financing Activities - Shenzhen Energy plans to apply for a public bond issuance with a total scale not exceeding RMB 20 billion [7] - Huakong Saige has terminated its specific object stock issuance [7]

每经AI快讯，金陵药业（SZ 000919，收盘价：7.26元）11月28日晚间发布公告称，公司第九届第二十 二次董事会会议于2025年11月28日以现场会议和通讯会议相结合的方式召开。会议审议了《关于提请召 开2025年第四次临时股东会的议案》等文件。 每经头条（nbdtoutiao）——已有75人遇难，1名死者为消防员，还有10名消防员受伤！记者现场直击香 港大埔火灾：燃烧的宏福苑，五级大火的五个谜团 2025年1至6月份，金陵药业的营业收入构成为：医疗收入占比50.44%，药品生产与销售占比48.5%，其 他行业占比1.06%。 截至发稿，金陵药业市值为45亿元。 （记者 张明双） ...

人民财讯11月28日电，金陵药业（000919）11月28日公告，控股子公司南京梅山医院为更好地满足辐射 区域内民众日益增长的健康需求，进一步提升医院医疗设施水平与服务能力，拟投资8.93亿元实施医院 改扩建项目。 ...